Cal27-derived Exosomes for site-specific Immunomodulation of natural killer cells in head and neck Squamous Cell Carcinoma
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S234
DOI: 10.1055/s-0044-1784767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Veena Ramesh und 6 weiteren Autor:innen.
Abstract (Originalsprache)
HNSCC, being a global health concern, is the seventh most common cancer worldwide. The exosomes released by these tumor cells play a significant role in immunoregulation and HNSCC progression. However, the specific role of exosomes released by Cal27-HNSCC cells is yet to be studied.
Methods
Cal27 cell lines are cultured in DMEM with 10% exosome-depleted FBS, for exosome isolation. Cell surface markers were determined on Cal27 tumor cells by flow cytometry. The exosomes are isolated from cell culture supernatants using size exclusion chromatography and the physical characteristics like size and morphology were measured using dynamic light scattering and transmission electron microscopy. The surface of these isolated exosomes was characterized for well-known tumor markers like Hsp70, CD9, CD63, and CD81 using flow cytometry. The binding affinity of surface Hsp70 positive exosomes to cmHsp70.1 monoclonal antibody (mAb) was determined by microscale thermophoresis and the influence of Cal27 derived exosomes on cytotoxic capacity of NK cells against Cal27 cells was investigated in cell death assays.
Results
Cal27-derived exosomes, with an average size distribution of ~100 nm, exhibit various cell-surface markers and possess significant immunomodulatory effects on NK cells. Our study reveals that Cal27 cells, besides tetraspanins (CD9, CD63, and CD81), express different immunoregulatory ligands (eg, PD-L1, HLA-E, Hsp70) for NK cells. Upon co-incubation of monocytes with Cal27-derived exosomes, we observed an impaired immune response and cytotoxicity of treated NK cells against tumor cells.
Discussion
Our findings highlight key implications for understanding HNSCC progression and developing a site-specific therapeutic strategy to modulate anti-cancer immune response. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Ramesh, V., Bakhtiar, A., Alkotub, B., Kafshgari, M. H., Ali, B. D., Multhoff, G., & Wollenberg, B. (2024). Cal27-derived Exosomes for site-specific Immunomodulation of natural killer cells in head and neck Squamous Cell Carcinoma. Laryngo-Rhino-Otologie, 103(S 02 S 02), S234. https://doi.org/10.1055/s-0044-1784767
Vancouver
Ramesh V, Bakhtiar A, Alkotub B, Kafshgari MH, Ali BD, Multhoff G, et al. Cal27-derived Exosomes for site-specific Immunomodulation of natural killer cells in head and neck Squamous Cell Carcinoma. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S234. doi:10.1055/s-0044-1784767
BibTeX
@article{Ramesh2024,
author = {Ramesh, Veena and Bakhtiar, Asajd and Alkotub, Bayan and Kafshgari, Morteza Hasanzadeh and Ali, Bashiri Dezfouli and Multhoff, Gabriele and Wollenberg, Barbara},
title = {Cal27-derived Exosomes for site-specific Immunomodulation of natural killer cells in head and neck Squamous Cell Carcinoma},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S234},
doi = {10.1055/s-0044-1784767}
}
EUVIMED